9 reports

  • UCB SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
  • UCB SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018

Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases.It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company’s key medicines include Cimzia...

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • UCB S.A.
  • UCB Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
  • UCB Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Summary UCB Inc (UCB), a subsidiary of UCB SA is a healthcare solutions provider that offers therapeutics.The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, metadate CD, and others.UCB’s...

  • Healthcare
  • Pharmaceutical
  • United States
  • UCB S.A.
  • NEWBRIDGE PHARMACEUTICALS TARGETS AND PARTNERS (2012 -YTD2016)
  • TARGETS AND PARTNERS

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' NewBridge...

  • Pharmaceutical
  • Company
  • Corporate Finance
  • Deals & Alliance
  • UCB S.A.
  • PROMINENT SPONSORS
  • PARTIAL SEIZURE THERAPEUTICS CLINICAL TRIALS, GLOBAL, KEY SPONSORS, 2018*

## ## ## ## ## ## ## Inconclusive ## ## ## ## ## ## ## ## Not Achieved ## ## ## ## ## ## ## ## Partially Achieved Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2018 2018 t

  • Clinical Trial
  • Pharmaceutical
  • Therapy
  • World
  • UCB S.A.
  • Prominent Sponsors
  • Clinical Trials by Sponsor Type

## ## ## ## ## ## Parexel International Corp ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## ## ## Eli Lilly and Company ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## Merck & Co Inc ## ## ## ## ## ## ##

  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • UCB S.A.
  • DIVESTMENTS - DEAL REPORTS
  • DIVESTMENTS - DEAL REPORTS

UCB S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital...

  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • M&A
  • UCB S.A.
  • DIVESTMENTS - DEAL REPORTS
  • DIVESTMENTS - DEAL REPORTS

UCB S.A. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline’s UCB S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital...

  • Healthcare
  • Pharmaceutical
  • Corporate Finance
  • M&A
  • UCB S.A.
  • FINANCIAL DEALS ACTIVITY OVERVIEW
  • UCB S.A.: TOP DEALS 2013 - 2017YTD*

We also outperformed our recurring EBITDA* to net debt ratio target of ##:## - two years earlier than expected.

  • Pharmaceutical
  • United States
  • World
  • Company
  • UCB S.A.
  • UCB S.A., Key Facts
  • Other Locations & Subsidiaries

Suite ## Raffles City Shanghai Office Tower ## Tibet Road Central Shanghai SHA ## China Tel: +## ## ## Fax: +## ## ## UCB Pharma GmbH Geiselbergstrasse ##-## ## Stiege/ ## Stock Wien ## Austria Tel: +## ## ## Fax: +## ## ## UCB Farma Brasil L

  • Pharmaceutical
  • Therapy
  • United States
  • Company Operations
  • UCB S.A.